Relationship of uptake and binding of an antileukemic phthalanilide to its biochemical and chemotherapeutic effects on P388 lymphocytic leukemia cells.
D000085:Acetates / Q000378:metabolism; D000813:Anilides / Q000378:metabolism* / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism* / Q000627:therapeutic use*; D046508:Culture Techniques; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D007945:Leukemia, Lymphoid / Q000188:drug therapy* / Q000378:metabolism*; D008055:Lipids / Q000096:biosynthesis*; D051379:Mice; D009363:Neoplasm Proteins / Q000096:biosynthesis; D012334:RNA, Neoplasm / Q000096:biosynthesis*; D013936:Thymidine / Q000378:metabolism
D000085:Acetates; D000813:Anilides; D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D008055:Lipids; D009363:Neoplasm Proteins; D012334:RNA, Neoplasm; D013936:Thymidine